Test Price
2,800 AEDโ Home Collection Available
DRD2 Gene & DYT11-Associated Dystonia NGS Panel in UAE | 2,800 AED | DHA Guidelines
Executive Summary & Core Metrics
- โ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015-accredited processing (Cert: INT/EGQ/2509DA/3139).
- โ Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection, 8 AM โ 11 PM daily.
- โ Clinical Guidance: Complimentary post-test telephonic interpretation by a DHA-licensed medical genetics consultant.
- โ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This advanced Next-Generation Sequencing (NGS) panel simultaneously evaluates the DRD2 gene and the DYT11-associated dystonia locus, providing clinicians with a high-resolution genomic roadmap for hereditary myoclonus-dystonia, movement disorders, and pharmacogenetic response prediction. By mapping the entire coding sequence and splice-site regions, the test delivers 99.9% analytical sensitivity for detecting pathogenic variants.
| Feature | Our DRD2/DYT11 NGS Panel | Closest Alternative (Single-Gene Testing) |
|---|---|---|
| Precision | Multi-gene NGS with full coding + splice-site coverage; 99.9% analytical sensitivity | Limited to one gene; may miss co-existing mutations |
| Methodology | LC-MS/MS-validated NGS on Illumina NovaSeq X Plus platform | Sanger sequencing or limited PCR |
| Turnaround Time | 3 to 4 Weeks (expedited report available) | 6 to 8 Weeks |
Physician Insight & Safety Protocols
โIn my clinical practice, a positive DRD2 or DYT11 variant never stands alone โ it must be interpreted alongside the patientโs full neurological examination and pedigree. This panel offers a powerful diagnostic anchor, but only a specialist can distinguish familial dystonia from acquired mimics. I encourage every patient to share the result with their treating neurologist before making therapeutic decisions.โ โ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
โ Advisory Notice on Medication Adjustments
Genetic variants in DRD2 may influence response to dopaminergic agents. However, it is crucial not to alter or discontinue any prescribed medication without the direct supervision of your treating physician. Only a qualified healthcare professional should guide changes based on genetic results.
Patient Safety & Exclusion Criteria
- Age below 18 years without legal guardian consent (in line with UAE Federal Law for minors).
- Inability to understand and sign the genetic counselling informed consent.
- Acute febrile illness or active infection at the venipuncture site at time of collection.
- Emergency Red Flags: Seek immediate emergency care if you experience sudden severe dystonic crisis, respiratory distress, or suicidal ideation โ this test is not a substitute for emergency evaluation.
Patient FAQ & Clinical Guidance
1. What conditions can this DRD2/DYT11 genetic test actually diagnose or predict?
This NGS panel identifies pathogenic variants in DRD2 and DYT11-associated genes, enabling precise molecular diagnosis of myoclonus-dystonia (DYT11), dopamine-related movement disorders, and pharmacogenetic profiles for anti-psychotic or anti-parkinsonian drugs. By mapping the entire coding sequence of these genes, the test can differentiate hereditary dystonia from sporadic conditions and inform targeted therapy choices, such as deep brain stimulation candidacy or avoidance of certain dopamine-blocking medications.
2. How is the sample collected, and what is the exact turnaround time?
A hospital-grade home collection team draws a small blood sample (4 mL in EDTA) or accepts a DNA FTA card โ all processed under ISO-certified cold-chain logistics delivered to the lab within hours. The genomic DNA undergoes high-coverage NGS; the standard reporting time is 3 to 4 weeks, with optional expedited processing for urgent clinical scenarios. Pre-test genetic counselling is mandatory and can be arranged via WhatsApp at +971 54 548 8731.
3. Is this officially approved by UAE health authorities and covered by insurance?
Yes, the DRD2/DYT11 panel is performed in a DHA-licensed facility (License Number 1143), fully compliant with Federal Law No. 2 of 2019 concerning health information technology and Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL). Many local and international insurance plans cover medically indicated genetic tests; our team provides direct billing verification and will confirm your coverage before scheduling. For insurance verification, send a message with your Emirates ID and policy number to WhatsApp +971 54 548 8731.
UAE Regulatory & Data Privacy Adherence
This service fully complies with the Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 concerning the use of information and communication technology in health fields. Clinical safety and patient consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. All genetic data is handled with strict confidentiality and in accordance with UAE data protection standards.
Clinical & Logistical Metadata
| Parameter | Details |
|---|---|
| Test Name | DRD2 Gene & DYT11-Associated Dystonia NGS Panel |
| Price (AED) | 2,800 |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA) or DNA FTA Card |
| Methodology Used | Next-Generation Sequencing (NGS) on Illumina NovaSeq X Plus |
| ICD-10-CM Code | G24.1 |
| LOINC Code | 69047-9 |
| DHA Facility License & Address | License 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians